Non-Small Cell Lung Cancer Coverage from Every Angle

Mariano Provencio, MD, PhD, on NSCLC: Results From the NADIM and NORA Trials

Posted: Wednesday, October 4, 2017

Mariano Provencio, MD, PhD, of the Hospital Universitario Puerta de Hierro, discusses study findings on neoadjuvant chemo/immunotherapy for the treatment of resectable stage IIIA non–small cell lung cancer; and concurrent chemoradiotherapy with cisplatin plus metronomic oral vinorelbine for unresectable, locally advanced disease.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.